• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

10 例 11β-羟化酶缺陷型先天性肾上腺皮质增生症患儿的临床和分子特征。

Clinical and molecular characterization of 10 Chinese children with congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.

机构信息

Department of Pediatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin 2nd Rd, Huangpu District, Shanghai, 200025, China.

Department of Pediatric Genetic and Metabolic Endocrinology, West China Second University Hospital,Sichuan University, No. 20, Section 3, Renmin South Road, Sichuan, 610041, China.

出版信息

World J Pediatr. 2024 Apr;20(4):422-433. doi: 10.1007/s12519-023-00739-1. Epub 2023 Jul 24.

DOI:10.1007/s12519-023-00739-1
PMID:37486441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11052800/
Abstract

BACKGROUND

The clinical manifestations of nonclassical 11beta-hydroxylase deficiency are very similar to those of non-classical 21-hydroxylase deficiency. For this study, we investigated the relationship between the clinical and molecular features of congenital adrenal hyperplasia caused by 11beta-hydroxylase deficiency and reviewed the related literature, which are expected to provide assistance for the clinical diagnosis and analysis of congenital adrenal hyperplasia.

METHODS

Clinical data for 10 Chinese patients diagnosed with congenital adrenal hyperplasia in our hospital from 2018 to 2022 were retrospectively analyzed. We examined the effects of gene mutations on protease activity and constructed three-dimensional structure prediction models of proteins.

RESULTS

We describe 10 patients with 11beta-hydroxylase gene mutations (n = 5, 46,XY; n = 5, 46,XX), with 10 novel mutations were reported. Female patients received treatment at an early stage, with an average age of 2.08 ± 1.66 years, whereas male patients received treatment significantly later, at an average age of 9.77 ± 3.62 years. The most common CYP11B1 pathogenic variant in the Chinese population was found to be c.1360C > T. All mutations lead to spatial conformational changes that affect protein stability.

CONCLUSIONS

Our study found that there was no significant correlation between each specific mutation and the severity of clinical manifestations. Different patients with the same gene pathogenic variant may have mild or severe clinical manifestations. The correlation between genotype and phenotype needs further study. Three-dimensional protein simulations may provide additional support for the physiopathological mechanism of genetic mutations.

摘要

背景

非典型 11β-羟化酶缺陷的临床表现与非典型 21-羟化酶缺陷非常相似。本研究旨在探讨 11β-羟化酶缺陷导致先天性肾上腺皮质增生的临床与分子特征之间的关系,并复习相关文献,以期为先天性肾上腺皮质增生的临床诊断和分析提供帮助。

方法

回顾性分析 2018 年至 2022 年我院收治的 10 例先天性肾上腺皮质增生症患者的临床资料,检测基因突变对蛋白酶活性的影响,并构建蛋白质三维结构预测模型。

结果

描述了 10 例 11β-羟化酶基因突变患者(n=5,46,XY;n=5,46,XX),报告了 10 种新突变。女性患者早期接受治疗,平均年龄为 2.08±1.66 岁,而男性患者接受治疗的年龄明显较晚,平均年龄为 9.77±3.62 岁。中国人群中最常见的 CYP11B1 致病变异是 c.1360C>T。所有突变导致空间构象改变,影响蛋白质稳定性。

结论

本研究发现,特定突变与临床表现严重程度之间无显著相关性。同一基因致病性变异的不同患者可能表现为轻度或重度临床表现。基因型与表型的相关性需要进一步研究。三维蛋白质模拟可能为基因突变的病理生理机制提供额外支持。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/01f77a84aba5/12519_2023_739_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/410167959ff9/12519_2023_739_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/8e1eb9f20d0a/12519_2023_739_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/eb0ea5bce4e5/12519_2023_739_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/ff96a7742653/12519_2023_739_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/01f77a84aba5/12519_2023_739_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/410167959ff9/12519_2023_739_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/8e1eb9f20d0a/12519_2023_739_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/eb0ea5bce4e5/12519_2023_739_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/ff96a7742653/12519_2023_739_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c88/11052800/01f77a84aba5/12519_2023_739_Fig5_HTML.jpg

相似文献

1
Clinical and molecular characterization of 10 Chinese children with congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.10 例 11β-羟化酶缺陷型先天性肾上腺皮质增生症患儿的临床和分子特征。
World J Pediatr. 2024 Apr;20(4):422-433. doi: 10.1007/s12519-023-00739-1. Epub 2023 Jul 24.
2
Compound heterozygosity of a novel Q73X mutation and a known R141X mutation in CYP11B1 resulting in 11β-hydroxylase deficiency in a Chinese boy with congenital adrenal hyperplasia.CYP11B1 中新型 Q73X 突变和已知 R141X 突变的复合杂合导致 1 例中国先天性肾上腺皮质增生症男孩 11β-羟化酶缺陷。
J Steroid Biochem Mol Biol. 2021 Jul;211:105882. doi: 10.1016/j.jsbmb.2021.105882. Epub 2021 Mar 27.
3
Prevalence, clinical characteristics and long-term outcomes of classical 11 β-hydroxylase deficiency (11BOHD) in Turkish population and novel mutations in CYP11B1 gene.土耳其人群中经典 11β-羟化酶缺乏症(11BOHD)的流行率、临床特征和长期预后及 CYP11B1 基因的新突变。
J Steroid Biochem Mol Biol. 2018 Jul;181:88-97. doi: 10.1016/j.jsbmb.2018.04.001. Epub 2018 Apr 4.
4
Novel and prevalent CYP11B1 gene mutations in Turkish patients with 11-β hydroxylase deficiency.土耳其11-β羟化酶缺乏症患者中新型且普遍存在的CYP11B1基因突变
J Steroid Biochem Mol Biol. 2017 Jan;165(Pt A):57-63. doi: 10.1016/j.jsbmb.2016.03.006. Epub 2016 Mar 5.
5
A Chinese patient with 11β-hydroxylase deficiency due to novel compound heterozygous mutation in CYP11B1 gene: a case report.一名因CYP11B1基因新型复合杂合突变导致11β-羟化酶缺乏的中国患者:病例报告
BMC Endocr Disord. 2018 Sep 21;18(1):68. doi: 10.1186/s12902-018-0295-6.
6
Molecular analysis of 12 Chinese patients with 11β-hydroxylase deficiency and in vitro functional study of 20 CYP11B1 missense variants.12例11β-羟化酶缺乏中国患者的分子分析及20种CYP11B1错义变异的体外功能研究
FASEB J. 2023 Apr;37(4):e22869. doi: 10.1096/fj.202201398RR.
7
Congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency: functional consequences of four CYP11B1 mutations.因11-β-羟化酶缺乏所致的先天性肾上腺皮质增生症:四种CYP11B1突变的功能后果
Eur J Hum Genet. 2014 May;22(5):610-6. doi: 10.1038/ejhg.2013.197. Epub 2013 Sep 11.
8
Novel homozygous p.Y395X mutation in the CYP11B1 gene found in a Vietnamese patient with 11β-hydroxylase deficiency.在一名越南 11β-羟化酶缺乏症患者中发现 CYP11B1 基因中的新型纯合 p.Y395X 突变。
Gene. 2012 Nov 10;509(2):295-7. doi: 10.1016/j.gene.2012.08.009. Epub 2012 Aug 17.
9
Two novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11β hydroxylase deficiency in a Tunisian family.在一个突尼斯家族中,类固醇 11β 羟化酶缺陷导致先天性肾上腺皮质增生症,发现了两种 CYP11B1 新突变。
Gen Comp Endocrinol. 2012 Feb 1;175(3):514-8. doi: 10.1016/j.ygcen.2011.12.017. Epub 2011 Dec 22.
10
Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.11β-羟化酶缺乏所致先天性肾上腺皮质增生症的分子遗传学研究进展
World J Pediatr. 2008 May;4(2):85-90. doi: 10.1007/s12519-008-0016-8.

引用本文的文献

1
Hirschsprung disease.先天性巨结肠症。
Nat Rev Dis Primers. 2023 Oct 12;9(1):54. doi: 10.1038/s41572-023-00465-y.

本文引用的文献

1
Clinical, genetic, and structural basis of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.11β-羟化酶缺乏所致先天性肾上腺皮质增生症的临床、遗传及结构基础
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):E1933-E1940. doi: 10.1073/pnas.1621082114. Epub 2017 Feb 22.
2
A diagnosis not to be missed: nonclassic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism.一个不容忽视的诊断:非经典型类固醇 11β-羟化酶缺陷症表现为性早熟和多毛症。
J Clin Endocrinol Metab. 2013 Oct;98(10):E1620-5. doi: 10.1210/jc.2013-1306. Epub 2013 Aug 12.
3
Novel homozygous p.R454C mutation in the CYP11B1 gene leads to 11β-hydroxylase deficiency in a Chinese patient.
中国患者 CYP11B1 基因中 novel homozygous p.R454C 突变导致 11β-羟化酶缺乏症。
Fertil Steril. 2011 Mar 1;95(3):1122.e3-6. doi: 10.1016/j.fertnstert.2010.09.035. Epub 2010 Oct 14.
4
A novel missense mutation, GGC(Arg454) --> TGC(Cys), of CYP11B1 gene identified in a Chinese family with steroid 11beta-hydroxylase deficiency.一个新的错义突变,GGC(精氨酸 454) -- > TGC(半胱氨酸),在一个有类固醇 11β-羟化酶缺乏的中国家庭的 CYP11B1 基因中被发现。
Chin Med J (Engl). 2010 May 20;123(10):1264-8.
5
Functional consequences of seven novel mutations in the CYP11B1 gene: four mutations associated with nonclassic and three mutations causing classic 11{beta}-hydroxylase deficiency.CYP11B1 基因七个新突变的功能后果:四个突变与非经典型相关,三个突变导致经典 11β-羟化酶缺乏。
J Clin Endocrinol Metab. 2010 Feb;95(2):779-88. doi: 10.1210/jc.2009-0651. Epub 2010 Jan 20.
6
Congenital adrenal hyperplasia due to 11-hydroxylase deficiency--insights from two novel CYP11B1 mutations (p.M92X, p.R453Q).11β-羟化酶缺乏所致先天性肾上腺皮质增生症——来自两个新型CYP11B1突变(p.M92X、p.R453Q)的见解
Horm Res. 2009;72(5):281-6. doi: 10.1159/000245930. Epub 2009 Oct 19.
7
A homozygous L299P mutation in the CYP11B1 gene leads to complete virilization in 46,XX individuals with 11-beta-hydroxylase deficiency.CYP11B1基因中的纯合L299P突变导致46,XX型11-β-羟化酶缺乏个体出现完全男性化。
Horm Res. 2008;70(3):145-9. doi: 10.1159/000137659. Epub 2008 Jul 29.
8
Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.11β-羟化酶缺乏所致先天性肾上腺皮质增生症的分子遗传学研究进展
World J Pediatr. 2008 May;4(2):85-90. doi: 10.1007/s12519-008-0016-8.
9
[11 beta hydroxylase deficiency: a clinical study of seven cases].[11β-羟化酶缺乏症:7例临床研究]
Tunis Med. 2006 Feb;84(2):106-13.
10
Analyzing the functional and structural consequences of two point mutations (P94L and A368D) in the CYP11B1 gene causing congenital adrenal hyperplasia resulting from 11-hydroxylase deficiency.分析CYP11B1基因中两个点突变(P94L和A368D)的功能和结构后果,这两个点突变导致因11β-羟化酶缺乏引起的先天性肾上腺皮质增生症。
J Clin Endocrinol Metab. 2006 Jul;91(7):2682-8. doi: 10.1210/jc.2006-0209. Epub 2006 May 2.